Presenilin 1 mutations increase amyloid precursor protein production and proteolysis in Xenopus laevis oocytes

Sietske N. Heyn, Philip R Vulliet

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Recent findings suggest that Presenilin 1 (PS1) mutations play a major role in the development of Alzheimer's disease (AD) by increasing the production of the beta amyloid peptide (Aβ). The exact mechanism whereby mutations in PS1 lead to this effect is not clear. To examine the question of how PS1 might be involved in amyloid precursor protein (APP) processing, we constructed a chimera of human APP695 fused at the C-terminal to enhanced green fluorescent protein (EGFP). This construct was injected into Xenopus laevis oocytes in the presence of wild type PS1 or one of three PS1 mutations associated with AD. The cellular location of the APP695-EGFP construct was examined by fluorescent confocal microscopy. In addition, membrane fractions of oocytes expressing APP695-EGFP in the presence or absence of wild type or mutant forms of PS1 were evaluated by Western blot analysis. The results show that APP695-EGFP is primarily expressed on the cell surface and undergoes limited cleavage. Specifically, APP695 was cleaved in the Aβ domain to generate three distinct C-terminal fragments that correspond in length to stubs expected after cleavage with α-, β- and γ-secretase, respectively. The presence of wild type PS1 not only increased the production of proteolytic C-terminal fragments of APP, but the production of APP itself. These findings were even more pronounced in the presence of all three PS1 mutations, suggesting that PS1 mutations may lead to over-expression of APP not just increased γ-secretase activity.

Original languageEnglish (US)
Pages (from-to)189-198
Number of pages10
JournalBrain Research
Volume904
Issue number2
DOIs
StatePublished - Jun 22 2001

Fingerprint

Presenilin-1
Amyloid beta-Protein Precursor
Xenopus laevis
Proteolysis
Oocytes
Mutation
Amyloid Precursor Protein Secretases
Alzheimer Disease
Amyloid
Confocal Microscopy
Western Blotting

Keywords

  • Alzheimer
  • Amyloid precursor protien
  • Beta amyloid
  • GFP
  • Presenilin 1
  • Xenopus laevis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Presenilin 1 mutations increase amyloid precursor protein production and proteolysis in Xenopus laevis oocytes. / Heyn, Sietske N.; Vulliet, Philip R.

In: Brain Research, Vol. 904, No. 2, 22.06.2001, p. 189-198.

Research output: Contribution to journalArticle

@article{d0b6dc91dcaf4d19a975b7f3ab0a0c25,
title = "Presenilin 1 mutations increase amyloid precursor protein production and proteolysis in Xenopus laevis oocytes",
abstract = "Recent findings suggest that Presenilin 1 (PS1) mutations play a major role in the development of Alzheimer's disease (AD) by increasing the production of the beta amyloid peptide (Aβ). The exact mechanism whereby mutations in PS1 lead to this effect is not clear. To examine the question of how PS1 might be involved in amyloid precursor protein (APP) processing, we constructed a chimera of human APP695 fused at the C-terminal to enhanced green fluorescent protein (EGFP). This construct was injected into Xenopus laevis oocytes in the presence of wild type PS1 or one of three PS1 mutations associated with AD. The cellular location of the APP695-EGFP construct was examined by fluorescent confocal microscopy. In addition, membrane fractions of oocytes expressing APP695-EGFP in the presence or absence of wild type or mutant forms of PS1 were evaluated by Western blot analysis. The results show that APP695-EGFP is primarily expressed on the cell surface and undergoes limited cleavage. Specifically, APP695 was cleaved in the Aβ domain to generate three distinct C-terminal fragments that correspond in length to stubs expected after cleavage with α-, β- and γ-secretase, respectively. The presence of wild type PS1 not only increased the production of proteolytic C-terminal fragments of APP, but the production of APP itself. These findings were even more pronounced in the presence of all three PS1 mutations, suggesting that PS1 mutations may lead to over-expression of APP not just increased γ-secretase activity.",
keywords = "Alzheimer, Amyloid precursor protien, Beta amyloid, GFP, Presenilin 1, Xenopus laevis",
author = "Heyn, {Sietske N.} and Vulliet, {Philip R}",
year = "2001",
month = "6",
day = "22",
doi = "10.1016/S0006-8993(01)02312-5",
language = "English (US)",
volume = "904",
pages = "189--198",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Presenilin 1 mutations increase amyloid precursor protein production and proteolysis in Xenopus laevis oocytes

AU - Heyn, Sietske N.

AU - Vulliet, Philip R

PY - 2001/6/22

Y1 - 2001/6/22

N2 - Recent findings suggest that Presenilin 1 (PS1) mutations play a major role in the development of Alzheimer's disease (AD) by increasing the production of the beta amyloid peptide (Aβ). The exact mechanism whereby mutations in PS1 lead to this effect is not clear. To examine the question of how PS1 might be involved in amyloid precursor protein (APP) processing, we constructed a chimera of human APP695 fused at the C-terminal to enhanced green fluorescent protein (EGFP). This construct was injected into Xenopus laevis oocytes in the presence of wild type PS1 or one of three PS1 mutations associated with AD. The cellular location of the APP695-EGFP construct was examined by fluorescent confocal microscopy. In addition, membrane fractions of oocytes expressing APP695-EGFP in the presence or absence of wild type or mutant forms of PS1 were evaluated by Western blot analysis. The results show that APP695-EGFP is primarily expressed on the cell surface and undergoes limited cleavage. Specifically, APP695 was cleaved in the Aβ domain to generate three distinct C-terminal fragments that correspond in length to stubs expected after cleavage with α-, β- and γ-secretase, respectively. The presence of wild type PS1 not only increased the production of proteolytic C-terminal fragments of APP, but the production of APP itself. These findings were even more pronounced in the presence of all three PS1 mutations, suggesting that PS1 mutations may lead to over-expression of APP not just increased γ-secretase activity.

AB - Recent findings suggest that Presenilin 1 (PS1) mutations play a major role in the development of Alzheimer's disease (AD) by increasing the production of the beta amyloid peptide (Aβ). The exact mechanism whereby mutations in PS1 lead to this effect is not clear. To examine the question of how PS1 might be involved in amyloid precursor protein (APP) processing, we constructed a chimera of human APP695 fused at the C-terminal to enhanced green fluorescent protein (EGFP). This construct was injected into Xenopus laevis oocytes in the presence of wild type PS1 or one of three PS1 mutations associated with AD. The cellular location of the APP695-EGFP construct was examined by fluorescent confocal microscopy. In addition, membrane fractions of oocytes expressing APP695-EGFP in the presence or absence of wild type or mutant forms of PS1 were evaluated by Western blot analysis. The results show that APP695-EGFP is primarily expressed on the cell surface and undergoes limited cleavage. Specifically, APP695 was cleaved in the Aβ domain to generate three distinct C-terminal fragments that correspond in length to stubs expected after cleavage with α-, β- and γ-secretase, respectively. The presence of wild type PS1 not only increased the production of proteolytic C-terminal fragments of APP, but the production of APP itself. These findings were even more pronounced in the presence of all three PS1 mutations, suggesting that PS1 mutations may lead to over-expression of APP not just increased γ-secretase activity.

KW - Alzheimer

KW - Amyloid precursor protien

KW - Beta amyloid

KW - GFP

KW - Presenilin 1

KW - Xenopus laevis

UR - http://www.scopus.com/inward/record.url?scp=0035933518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035933518&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(01)02312-5

DO - 10.1016/S0006-8993(01)02312-5

M3 - Article

C2 - 11406116

AN - SCOPUS:0035933518

VL - 904

SP - 189

EP - 198

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -